))
Faculty Interview & Free CME/NCPD Activity: Graft-Versus-Host Disease
Manage episode 364452913 series 3456244
Contenido proporcionado por i3 Health and I3 Health. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente i3 Health and I3 Health o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Click here to claim CME/NCPD credit for this activity: i3health.com/oda-gvhd This audio includes both the additional updates interview and complete podcast from i3 Health’s CME/NCPD activity New Opportunities for Improved Patient Outcomes in Graft-Versus-Host Disease. First, listen along as Dr. Shernan Holtan shares the latest data from the BTM CTN 1703 trial of posttransplant cyclophosphamide, tacrolimus, and mycophenolate mofetil as GVHD prophylaxis after allogeneic hematopoietic cell transplantation, then stay tuned after the interview to listen along to the full activity.
…
continue reading
41 episodios
Compartir
